Articoli di riviste sul tema "Antiretroviral agents"
Cita una fonte nei formati APA, MLA, Chicago, Harvard e in molti altri stili
Vedi i top-50 articoli di riviste per l'attività di ricerca sul tema "Antiretroviral agents".
Accanto a ogni fonte nell'elenco di riferimenti c'è un pulsante "Aggiungi alla bibliografia". Premilo e genereremo automaticamente la citazione bibliografica dell'opera scelta nello stile citazionale di cui hai bisogno: APA, MLA, Harvard, Chicago, Vancouver ecc.
Puoi anche scaricare il testo completo della pubblicazione scientifica nel formato .pdf e leggere online l'abstract (il sommario) dell'opera se è presente nei metadati.
Vedi gli articoli di riviste di molte aree scientifiche e compila una bibliografia corretta.
Chaudry, Muddasar N., e David H. Shepp. "ANTIRETROVIRAL AGENTS". Dermatologic Clinics 15, n. 2 (aprile 1997): 319–30. http://dx.doi.org/10.1016/s0733-8635(05)70440-x.
Testo completoKraus, George A., Alex Melekhov, Susan Carpenter, Yvonne Wannemuhler e Jacob Petrich. "Phenanthrenequinone antiretroviral agents". Bioorganic & Medicinal Chemistry Letters 10, n. 1 (gennaio 2000): 9–11. http://dx.doi.org/10.1016/s0960-894x(99)00589-2.
Testo completoSiegel, Lawrence, e Roy M. Gulick. "New antiretroviral agents". Current Infectious Disease Reports 9, n. 3 (27 aprile 2007): 243–51. http://dx.doi.org/10.1007/s11908-007-0038-8.
Testo completoCambou, Mary C., e Raphael J. Landovitz. "Novel Antiretroviral Agents". Current HIV/AIDS Reports 17, n. 2 (12 febbraio 2020): 118–24. http://dx.doi.org/10.1007/s11904-020-00486-2.
Testo completoHarris, Marianne. "Raltegravir: Its use in the Treatment of HIV Infection". Clinical Medicine. Therapeutics 1 (gennaio 2009): CMT.S32. http://dx.doi.org/10.4137/cmt.s32.
Testo completo&NA;. "GUIDELINES FOR ANTIRETROVIRAL AGENTS". American Journal of Nursing 100, n. 5 (maggio 2000): 17. http://dx.doi.org/10.1097/00000446-200005000-00019.
Testo completoCollura, Jennifer M., e Donna M. Kraus. "New pediatric antiretroviral agents". Journal of Pediatric Health Care 14, n. 4 (luglio 2000): 183–92. http://dx.doi.org/10.1067/mph.2000.107924.
Testo completoOwen, Andrew, e Saye H. Khoo. "Pharmacogenetics of antiretroviral agents". Current Opinion in HIV and AIDS 3, n. 3 (maggio 2008): 288–95. http://dx.doi.org/10.1097/coh.0b013e3282f7cda4.
Testo completoCOLLURA, J., e D. KRAUS. "New pediatric antiretroviral agents". Journal of Pediatric Health Care 14, n. 4 (luglio 2000): 183–92. http://dx.doi.org/10.1016/s0891-5245(00)27765-1.
Testo completoStruble, Kimberly A., R. Douglas Pratt e Steven R. Gitterman. "Toxicity of antiretroviral agents". American Journal of Medicine 102, n. 5 (maggio 1997): 65–67. http://dx.doi.org/10.1016/s0002-9343(97)00065-x.
Testo completoGhebremedhin, Beniam. "Maraviroc in Antiretroviral-Naïve HIV-1 Patients". Infectious Diseases: Research and Treatment 5 (gennaio 2012): IDRT.S7597. http://dx.doi.org/10.4137/idrt.s7597.
Testo completoYakiwchuk, Erin M., Michelle M. Foisy e Christine A. Hughes. "Complexity of Interactions Between Voriconazole and Antiretroviral Agents". Annals of Pharmacotherapy 42, n. 5 (15 aprile 2008): 698–703. http://dx.doi.org/10.1345/aph.1k530.
Testo completoAbu-Awwad, Simona-Alina, Ahmed Abu-Awwad, Madalina-Ianca Suba, Voichita Elena Lazureanu, Andrei-Daniel Bolovan, Ovidiu Rosca, Mirela-Mădălina Turaiche, Adela-Teodora Benea e Bogdan Hogea. "Evaluating Hepatotoxicity: A Comparative Analysis of New Generation versus Historical Antiretroviral Agents". Infectious Disease Reports 16, n. 3 (24 aprile 2024): 423–34. http://dx.doi.org/10.3390/idr16030031.
Testo completoSutherland, David C. "Antiretroviral agents in the nineties". Medical Journal of Australia 157, n. 2 (luglio 1992): 135–38. http://dx.doi.org/10.5694/j.1326-5377.1992.tb137049.x.
Testo completoBarber, Tristan J., e Alan Winston. "Pharmacokinetics of experimental antiretroviral agents". Future Virology 2, n. 1 (gennaio 2007): 39–48. http://dx.doi.org/10.2217/17460794.2.1.39.
Testo completoBang, Ji Hwan. "Recent Advances of Antiretroviral Agents". Korean Journal of Medicine 90, n. 6 (1 giugno 2016): 481–86. http://dx.doi.org/10.3904/kjm.2016.90.6.481.
Testo completoKraus, George A., Alex Melekhov, Susan Carpenter, Yvonne Wannemuhler e Jacob Petrich. "ChemInform Abstract: Phenanthrenequinone Antiretroviral Agents." ChemInform 31, n. 18 (8 giugno 2010): no. http://dx.doi.org/10.1002/chin.200018174.
Testo completoMascolini, Mark, Douglas Richman, Brendan Larder, John Mellors e Charles AB Boucher. "Clinical Implications of Resistance to Antiretrovirals: New Resistance Technologies and Interpretations". Antiviral Therapy 13, n. 2 (febbraio 2008): 319–34. http://dx.doi.org/10.1177/135965350801300211.
Testo completoSchnittman, Steven M. "Treatment of HIV-1 Infection with Combination Therapy: Antiretroviral Agents and Biological Response Modifiers". Canadian Journal of Infectious Diseases 5, suppl a (1994): 42A—46A. http://dx.doi.org/10.1155/1994/134340.
Testo completoMouradjian, Mallory T., Emily L. Heil, Hyunuk Sueng e Neha Sheth Pandit. "Virologic suppression in patients with a documented M184V/I mutation based on the number of active agents in the antiretroviral regimen". SAGE Open Medicine 8 (gennaio 2020): 205031212096057. http://dx.doi.org/10.1177/2050312120960570.
Testo completoPermanyer, Marc, Ester Ballana, Alba Ruiz, Roger Badia, Eva Riveira-Munoz, Encarna Gonzalo, Bonaventura Clotet e José A. Esté. "Antiretroviral Agents Effectively Block HIV Replication after Cell-to-Cell Transfer". Journal of Virology 86, n. 16 (13 giugno 2012): 8773–80. http://dx.doi.org/10.1128/jvi.01044-12.
Testo completoBuss, Neil, e Nick Cammack. "Measuring the Effectiveness of Antiretroviral Agents". Antiviral Therapy 6, n. 1 (gennaio 2001): 1–7. http://dx.doi.org/10.1177/135965350100600101.
Testo completoBoffito, Marta, David Back e José M. Gatell. "Twenty years of boosting antiretroviral agents". AIDS 29, n. 17 (novembre 2015): 2229–33. http://dx.doi.org/10.1097/qad.0000000000000800.
Testo completoDudley, M. N. "Clinical Pharmacokinetics Of Nucleoside Antiretroviral Agents". Journal of Infectious Diseases 171, Supplement 2 (1 marzo 1995): S99—S112. http://dx.doi.org/10.1093/infdis/171.supplement_2.s99.
Testo completoFlexner, Charles. "New antiretroviral agents in clinical development". Current Opinion in Infectious Diseases 5, n. 6 (dicembre 1992): 798–805. http://dx.doi.org/10.1097/00001432-199212000-00009.
Testo completoStanic, Anela, e Tulip K. Schneider. "Overview of Antiretroviral Agents in 2005". Journal of Pharmacy Practice 18, n. 4 (agosto 2005): 228–46. http://dx.doi.org/10.1177/0897190005278612.
Testo completoMyers, M. W. "New Antiretroviral Agents in the Clinic". Clinical Infectious Diseases 12, n. 5 (1 settembre 1990): 944–50. http://dx.doi.org/10.1093/clinids/12.5.944.
Testo completoMAHONEY, DIANA. "Antiretroviral Agents Prevent HIV-1 Infection". Family Practice News 42, n. 13 (agosto 2012): 24. http://dx.doi.org/10.1016/s0300-7073(12)70542-x.
Testo completoReed, Caitlin, e Eric S. Daar. "Novel antiretroviral agents in HIV therapy". Current Infectious Disease Reports 8, n. 6 (novembre 2006): 489–96. http://dx.doi.org/10.1007/s11908-006-0024-6.
Testo completoHughes, Christine A., Michelle Foisy e Alice Tseng. "Interactions between antifungal and antiretroviral agents". Expert Opinion on Drug Safety 9, n. 5 (29 marzo 2010): 723–42. http://dx.doi.org/10.1517/14740331003752694.
Testo completoMorris, Jennifer L., e Donna M. Kraus. "New Antiretroviral Therapies for Pediatric HIV Infection". Journal of Pediatric Pharmacology and Therapeutics 10, n. 4 (1 ottobre 2005): 215–47. http://dx.doi.org/10.5863/1551-6776-10.4.215.
Testo completoThenin-Houssier, Suzie, e Susana T. Valente. "HIV-1 Capsid Inhibitors as Antiretroviral Agents". Current HIV Research 14, n. 3 (4 marzo 2016): 270–82. http://dx.doi.org/10.2174/1570162x14999160224103555.
Testo completoLange, Joep MA, e Jintanat Ananworanich. "The discovery and development of antiretroviral agents". Antiviral Therapy 19, Suppl 3 (2014): 5–14. http://dx.doi.org/10.3851/imp2896.
Testo completoNikolopoulos, Georgios, Stefanos Bonovas, Argirios Tsantes e Nikolaos Sitaras. "HIV/AIDS: Recent Advances in Antiretroviral Agents". Mini-Reviews in Medicinal Chemistry 9, n. 8 (1 luglio 2009): 900–910. http://dx.doi.org/10.2174/138955709788681609.
Testo completoFridland, Arnold, Michele C. Connelly e Brian L. Robbins. "Cellular Factors for Resistance against Antiretroviral Agents". Antiviral Therapy 5, n. 3 (1 aprile 1999): 181–85. http://dx.doi.org/10.1177/135965350000500301.
Testo completoHusstedt, IW, D. Reichelt, U. Oelker-Grueneberg e S. Evers. "Neurotoxic effect of antiretroviral agents on CNS". Journal of the International AIDS Society 11, Suppl 1 (2008): P163. http://dx.doi.org/10.1186/1758-2652-11-s1-p163.
Testo completoAntoniou, Tony, e Alice Lin-In Tseng. "Interactions between Recreational Drugs and Antiretroviral Agents". Annals of Pharmacotherapy 36, n. 10 (ottobre 2002): 1598–613. http://dx.doi.org/10.1345/aph.1a447.
Testo completoTreisman, Glenn J., e Adam I. Kaplin. "Neurologic and psychiatric complications of antiretroviral agents". AIDS 16, n. 9 (giugno 2002): 1201–15. http://dx.doi.org/10.1097/00002030-200206140-00002.
Testo completoBurger, David, Erik Stroes e Peter Reiss. "Drug interactions between statins and antiretroviral agents". Current Opinion in HIV and AIDS 3, n. 3 (maggio 2008): 247–51. http://dx.doi.org/10.1097/coh.0b013e3282fbaa54.
Testo completoSavatier, Nathalie, Didier Rocancourt, Claire Bonnerot e Jean-François Nicolas. "A novel system for screening antiretroviral agents". Journal of Virological Methods 26, n. 2 (novembre 1989): 229–35. http://dx.doi.org/10.1016/0166-0934(89)90153-5.
Testo completoMcNicholl, Ian, e Joan McNicholl. "On the Horizon: Promising Investigational Antiretroviral Agents". Current Pharmaceutical Design 12, n. 9 (1 marzo 2006): 1091–103. http://dx.doi.org/10.2174/138161206776055804.
Testo completoJohnson, R. Paul, e Robert T. Schooley. "Update on antiretroviral agents other than zidovudine". Aids 3, Supplement (gennaio 1989): S145–152. http://dx.doi.org/10.1097/00002030-198901001-00022.
Testo completoRaines, Charles, Olivia Radcliffe e Glenn J. Treisman. "Neurologic and Psychiatric Complications of Antiretroviral Agents". Journal of the Association of Nurses in AIDS Care 16, n. 5 (settembre 2005): 35–48. http://dx.doi.org/10.1016/j.jana.2005.07.004.
Testo completoOtto, Ashley O., Christina G. Rivera, John D. Zeuli e Zelalem Temesgen. "Hepatotoxicity of Contemporary Antiretroviral Drugs: A Review and Evaluation of Published Clinical Data". Cells 10, n. 5 (20 maggio 2021): 1263. http://dx.doi.org/10.3390/cells10051263.
Testo completoAtta, Mohamed G., Sophie De Seigneux e Gregory M. Lucas. "Clinical Pharmacology in HIV Therapy". Clinical Journal of the American Society of Nephrology 14, n. 3 (29 maggio 2018): 435–44. http://dx.doi.org/10.2215/cjn.02240218.
Testo completoHarrigan, P. Richard, e Brendan A. Larder. "Extent of Cross-Resistance between Agents Used To Treat Human Immunodeficiency Virus Type 1 Infection in Clinically Derived Isolates". Antimicrobial Agents and Chemotherapy 46, n. 3 (marzo 2002): 909–12. http://dx.doi.org/10.1128/aac.46.3.909-912.2002.
Testo completoOnukak, E. E., A. E. Onukak, E. C. Akwiwu e J. O. Akpotuzor. "Impact of Antiretroviral Agents on Blood Cell Parameters". Sokoto Journal of Medical Laboratory Science 8, n. 1 (27 maggio 2023): 44–55. http://dx.doi.org/10.4314/sokjmls.v8i1.6.
Testo completoHoetdmans, Richard MW. "Pharmacology of Antiretroviral Drugs". Antiviral Therapy 4, n. 3_suppl (1 aprile 1998): 29–41. http://dx.doi.org/10.1177/135965359900403s01.
Testo completoDoran, Cynthia M. "New Approaches to Using Antiretroviral Therapy for the Management of Hiv Infection". Annals of Pharmacotherapy 31, n. 2 (febbraio 1997): 228–36. http://dx.doi.org/10.1177/106002809703100215.
Testo completoMarino-Merlo, Francesca, Emanuela Balestrieri, Claudia Matteucci, Antonio Mastino, Sandro Grelli e Beatrice Macchi. "Antiretroviral Therapy in HTLV-1 Infection: An Updated Overview". Pathogens 9, n. 5 (1 maggio 2020): 342. http://dx.doi.org/10.3390/pathogens9050342.
Testo completo